Search Results 1211-1220 of 11253 for Antifungal Resistance

  1. Clinical trials - Oncology (Medical)

    ... resistant to therapy. These activities are a first step toward identifying alternative therapies and subsequently beginning to personalize the therapy for ...

  2. A Study To Evaluate The Effectiveness And Safety Of Ralinepag To Improve Treatment Outcomes In Peripheral Arterial Hypertension (PAH) Patients - Mayo Clinic

    ≤12 mmHg if pulmonary vascular resistance (PVR) ≥240 to <500 dynes/sec/cm5; OR; ≤15 mmHg if PVR ≥500 dynes/sec/cm5;; If PCWP is not available, then left ...

  3. Treatment of recurrent CDI: Examining the efficacy and safety of standardized live biotherapeutics as microbiota restoration therapies - Mayo Clinic

    "Researchers theorize that spore-forming bacteria may help restore the microbiome and resistance to C. difficile by competing for essential nutrients and by ...

  4. Allergic Diseases: Hirohito Kita - Research Projects

    The Allergic Diseases Lab of Hirohito Kita, M.D., at Mayo Clinic studies eosinophil biology, chronic sinusitis, environmental allergens, airway exposure to ...

  5. A Study Of Intravital Microscopy (IVM) In Human Solid Tumors - Mayo Clinic

    The purpose of this study is to determine the feasibility of performing HIVM in patients with deep space solid tumors during standard course of surgical ...

  6. Study To Evaluate The Safety, Tolerability And Preliminary Antitumor Activity Of INCB059872 In Patients With Relapsed/Refractory Ewing Sarcoma - Mayo Clinic

    Chronic or current active infectious disease requiring systemic antibiotics, antifungal, or antiviral treatment, unless approved by medical monitor. Prior ...

  7. Oral AMXT 1501 Dicaprate In Combination With IV DFMO - Mayo Clinic

    Platinum resistant* ovarian cancer (including - primary peritoneal cancer and fallopian tube cancer);; Breast cancer;; Papillary thyroid cancer;; Head and neck ...

  8. Rheumatology - Doctors - Mayo Clinic

    Mayo Clinic has one of the largest and most experienced practices in the United States, with campuses in Arizona, Florida and Minnesota.

  9. Jennifer E. Fugate, D.O. - Mayo Clinic Faculty Profiles

    She studies anoxic ischemic brain injury, posterior reversible encephalopathy syndrome and acute stroke including aneurysmal subarachnoid hemorrhage. Dr. Fugate ...

  10. Researchers seek to improve success of chimeric antigen receptor-T cell therapy in non-Hodgkin lymphoma - Mayo Clinic News Network

    "Lasting remission in this setting ranges from 30% to 40%," so it is critical to identify a predictive biomarker to measure CAR-T cell resistance so we can ...